Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study.
about
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic strokeLow-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic strokeRates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar.Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articlesAntithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.Individual patient data meta-analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients.Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United StatesThrombo-prophylaxis in acutely ill medical and critically ill patients.Medical management of patients with an acute stroke: treatment and prevention.Prevention of venous thromboembolism after stroke.The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patientsAnticoagulant therapy for ischemic stroke: A review of literature.Primary prevention of venous thromboembolism in long-term care: identifying and managing the risk.Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patients.The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.Prevention of deep vein thrombosis and pulmonary embolism in patients with stroke.Heparin and related drugs for venous thromboembolism prophylaxis: subcutaneous or intravenous continuous infusion?Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism.D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity.Guidelines for prevention of venous thromboembolism in immobile patients secondary to neurological impairment.
P2860
Q24241831-CF9A98C3-95DC-4353-A6DA-75B920946836Q24244100-3AE4F163-080C-4F25-93AD-50FD9B53A649Q24795717-E8774127-6E88-481F-9285-3104EEFC939CQ28217686-F8D22C66-70CF-4110-A514-52B89664AC3EQ30484358-B54D53B9-299F-4B8A-A329-5AAAF61BE17DQ33792528-45C0DA66-F2F8-4326-9863-36486F950AA1Q34580375-571A8025-0425-4F72-906F-18C6CA7EA644Q35199938-3775CEBC-DDCC-4E7C-BFC6-6B8C273C9587Q35610113-D7863B65-B4DD-4355-8752-769D36DEF43AQ35610118-A35F0873-E519-4F79-9369-099ECB3F57B5Q35939263-606EC479-7C39-40F0-BFBA-20397B4A8FB9Q36477578-181020AB-2A8B-4C59-B360-4F1795BF07E9Q37121326-AD21E530-2421-46E0-B88D-933930E41347Q37516892-744C4570-099A-4CDB-B2E6-B3332FC6FCD2Q37554499-57A8473D-F2EE-496A-9570-0071A4732243Q37789425-750A840C-6CEB-42AC-B314-518DDA207EA1Q37898337-3C4CEA03-4F79-49F2-AC91-260829D001ECQ38397169-09726E35-3AF6-4440-841C-1AD2025A067CQ41552749-5321920A-5E58-4DF9-9B50-28303DD9BC89Q42718620-939C5C4B-8F2C-4FC3-86DD-AB2792AABA10Q46574831-048A6D55-780A-450C-AB44-1A97E61B504BQ50913338-86989879-D3F0-46C2-B166-C2E3398E16DD
P2860
Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Enoxaparin vs heparin for prev ...... andomized, double-blind study.
@en
Enoxaparin vs heparin for prev ...... andomized, double-blind study.
@nl
type
label
Enoxaparin vs heparin for prev ...... andomized, double-blind study.
@en
Enoxaparin vs heparin for prev ...... andomized, double-blind study.
@nl
prefLabel
Enoxaparin vs heparin for prev ...... andomized, double-blind study.
@en
Enoxaparin vs heparin for prev ...... andomized, double-blind study.
@nl
P2093
P2860
P1476
Enoxaparin vs heparin for prev ...... andomized, double-blind study.
@en
P2093
P2860
P356
10.1034/J.1600-0404.2002.01215.X
P407
P577
2002-08-01T00:00:00Z